CY1110116T1 - Νευροεκφυλιστικοι δεικτες για καταθλιψη - Google Patents
Νευροεκφυλιστικοι δεικτες για καταθλιψηInfo
- Publication number
- CY1110116T1 CY1110116T1 CY20101100535T CY101100535T CY1110116T1 CY 1110116 T1 CY1110116 T1 CY 1110116T1 CY 20101100535 T CY20101100535 T CY 20101100535T CY 101100535 T CY101100535 T CY 101100535T CY 1110116 T1 CY1110116 T1 CY 1110116T1
- Authority
- CY
- Cyprus
- Prior art keywords
- neuroendocrine
- indicators
- depression
- disease
- values
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
- G01N33/9406—Neurotransmitters
- G01N33/942—Serotonin, i.e. 5-hydroxy-tryptamine
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Food Science & Technology (AREA)
- General Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Eye Examination Apparatus (AREA)
- Medicines Containing Plant Substances (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Mushroom Cultivation (AREA)
- Input From Keyboards Or The Like (AREA)
Abstract
Η παρούσα εφεύρεση αφορά μεθόδους ανίχνευσης μιας ψυχιατρικής κατάστασης προαιρετικώς συνδυασμένη με μια κατάθλιψη, που περιλαμβάνει τα στάδια μέτρησης της συγκέντρωσης τουλάχιστον ενός in vivo προϊόντος αποικοδόμησης της τρυπτοφάνης. Περαιτέρω, η παρούσα εφεύρεση αφορά τη χρήση των εν λόγω τιμών ως δεικτών πρόβλεψης για την ανίχνευση μιας ψυχιατρικής κατάστασης που προαιρετικά συνδυάζεται με κατάθλιψη και ένα κιτ που περιέχει μέσα για ανίχνευση των εν λόγω τιμών.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05007558 | 2005-04-06 | ||
EP06723873A EP1866650B1 (en) | 2005-04-06 | 2006-03-30 | Neurodegenerative markers for depression. |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1110116T1 true CY1110116T1 (el) | 2015-01-14 |
Family
ID=36293430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20101100535T CY1110116T1 (el) | 2005-04-06 | 2010-06-11 | Νευροεκφυλιστικοι δεικτες για καταθλιψη |
Country Status (14)
Country | Link |
---|---|
US (2) | US20080131921A1 (el) |
EP (2) | EP1866650B1 (el) |
JP (1) | JP4958893B2 (el) |
AT (2) | ATE534038T1 (el) |
CY (1) | CY1110116T1 (el) |
DE (1) | DE602006014379D1 (el) |
DK (2) | DK1866650T3 (el) |
ES (2) | ES2346467T3 (el) |
HK (1) | HK1137219A1 (el) |
NO (2) | NO20075671L (el) |
PL (2) | PL2146209T3 (el) |
PT (2) | PT2146209E (el) |
SI (1) | SI1866650T1 (el) |
WO (1) | WO2006105907A1 (el) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2053405A4 (en) * | 2006-08-04 | 2009-11-11 | Ajinomoto Kk | METHOD FOR EVALUATING STRESS, STRESS EVALUATION DEVICE, STRESS EVALUATION METHOD, STRESS EVALUATION SYSTEM, STRESS EVALUATION PROGRAM AND RECORDING MEDIUM |
AT9843U1 (de) | 2007-03-27 | 2008-04-15 | Kepplinger Berthold Dr | Messung von biologischen markern |
NZ602007A (en) | 2008-01-18 | 2014-09-26 | Harvard College | Methods of detecting signatures of disease or conditions in bodily fluids |
WO2009096502A1 (ja) * | 2008-01-31 | 2009-08-06 | Japan As Represented By President Of National Center Of Neurology And Psychiatry | うつ病およびうつ状態のマーカーおよびそれを用いた検出・診断 |
WO2009100243A2 (en) * | 2008-02-05 | 2009-08-13 | University Of Miami | Elavl4 as a predictor of depression in alzheimer's disease and parkinson's disease patients |
JPWO2011019072A1 (ja) | 2009-08-12 | 2013-01-17 | ヒューマン・メタボローム・テクノロジーズ株式会社 | うつ病のバイオマーカー、うつ病のバイオマーカーの測定法、コンピュータプログラム、及び記憶媒体 |
WO2012012717A1 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting prenatal or pregnancy-related diseases or conditions |
SG10201505724SA (en) | 2010-07-23 | 2015-09-29 | Harvard College | Methods of detecting diseases or conditions using phagocytic cells |
EP4303584A3 (en) | 2010-07-23 | 2024-04-03 | President and Fellows of Harvard College | Methods for detecting signatures of disease or conditions in bodily fluids |
WO2012012694A2 (en) | 2010-07-23 | 2012-01-26 | President And Fellows Of Harvard College | Methods of detecting autoimmune or immune-related diseases or conditions |
CN106399458A (zh) | 2011-11-10 | 2017-02-15 | 福满代谢组技术有限公司 | 乙醇胺磷酸酯的测定方法 |
MX2014015434A (es) | 2012-06-15 | 2015-07-14 | Harry Stylli | Metodos para detectar enfermedades o condiciones utilizando celulas enfermas en circulacion. |
KR20150035821A (ko) | 2012-06-15 | 2015-04-07 | 해리 스타일리 | 질환 또는 병태를 검출하는 방법 |
US20150285805A1 (en) | 2012-11-05 | 2015-10-08 | Ospedale San Raffaele S.R.L. | Biomarkers of multiple myeloma development and progression |
US10494675B2 (en) | 2013-03-09 | 2019-12-03 | Cell Mdx, Llc | Methods of detecting cancer |
EP3385717A3 (en) | 2013-03-09 | 2018-10-24 | Harry Stylli | Methods of detecting prostate cancer |
EP2799878A1 (en) * | 2013-05-03 | 2014-11-05 | SALION GmbH | In vitro method for the early detection of a potential inflammation, in particular associated with rejection of a transplant using kynurenine as a marker. |
US20160003857A1 (en) * | 2014-07-02 | 2016-01-07 | Cecil Bennett | Methods and systems for detecting polypharmacy |
MA40636A (fr) | 2014-09-11 | 2015-09-11 | Colleen Kelly | Procédés pour détecter le cancer de la prostate |
US11806385B2 (en) | 2016-04-22 | 2023-11-07 | Board Of Regents Of The University Of Nebraska | Biomarkers for monitoring immune transformation |
EP3413050A1 (en) * | 2017-06-08 | 2018-12-12 | SALION GmbH | In vitro method for the determination of neurodegenerative diseases |
CA3077211A1 (en) * | 2017-09-27 | 2019-04-04 | University of North Carolina Wilmington | Human waste water and human-derived pathogen scouting tool |
KR20200134205A (ko) | 2018-03-19 | 2020-12-01 | 후지필름 와코 준야쿠 가부시키가이샤 | 정신 질환의 판정 방법 |
WO2019182003A1 (ja) * | 2018-03-22 | 2019-09-26 | 株式会社日本医療機器技研 | 生体吸収性ステント |
KR102159344B1 (ko) * | 2019-08-05 | 2020-09-23 | 한국과학기술연구원 | 행위 중독의 진단용 조성물, 키트 및 이를 이용한 행위 중독의 진단을 위한 키누레닌의 검출 방법 |
EP4067903A4 (en) * | 2019-11-26 | 2024-03-06 | Kyocera Corporation | LOAD MEASUREMENT SYSTEM AND LOAD MEASUREMENT METHOD |
JP2023549028A (ja) * | 2020-10-06 | 2023-11-22 | 学校法人沖縄科学技術大学院大学学園 | アルツハイマー病(ad)の診断のための指標を得るための方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6194217B1 (en) * | 1980-01-14 | 2001-02-27 | Esa, Inc. | Method of diagnosing or categorizing disorders from biochemical profiles |
JP2000131318A (ja) * | 1998-10-22 | 2000-05-12 | Nikken Foods Co Ltd | 快・不快ストレス状態解析方法 |
EP1050758A1 (en) * | 1999-05-03 | 2000-11-08 | Evotec BioSystems AG | Methods of diagnosing or treating neuropsychiatric diseases on basis of increased cerebrospinal fluid levels of neurotrophin 3 |
FR2827045B1 (fr) * | 2001-07-05 | 2007-08-10 | Univ Pasteur | Methodes et compositions pour la selection et le developpement de nouveaux agents pharmacologiques ou de nouveaux medicaments |
JP2004198325A (ja) * | 2002-12-19 | 2004-07-15 | Oriental Yeast Co Ltd | ストレスの測定方法 |
-
2006
- 2006-03-30 ES ES06723873T patent/ES2346467T3/es active Active
- 2006-03-30 DK DK06723873.3T patent/DK1866650T3/da active
- 2006-03-30 EP EP06723873A patent/EP1866650B1/en not_active Not-in-force
- 2006-03-30 PT PT09013088T patent/PT2146209E/pt unknown
- 2006-03-30 ES ES09013088T patent/ES2377704T3/es active Active
- 2006-03-30 DE DE602006014379T patent/DE602006014379D1/de active Active
- 2006-03-30 PT PT06723873T patent/PT1866650E/pt unknown
- 2006-03-30 SI SI200630658T patent/SI1866650T1/sl unknown
- 2006-03-30 JP JP2008504669A patent/JP4958893B2/ja not_active Expired - Fee Related
- 2006-03-30 EP EP09013088A patent/EP2146209B1/en not_active Not-in-force
- 2006-03-30 PL PL09013088T patent/PL2146209T3/pl unknown
- 2006-03-30 DK DK09013088.1T patent/DK2146209T3/da active
- 2006-03-30 PL PL06723873T patent/PL1866650T3/pl unknown
- 2006-03-30 WO PCT/EP2006/002907 patent/WO2006105907A1/en active Application Filing
- 2006-03-30 AT AT09013088T patent/ATE534038T1/de active
- 2006-03-30 AT AT06723873T patent/ATE468537T1/de active
- 2006-03-30 US US11/887,486 patent/US20080131921A1/en not_active Abandoned
-
2007
- 2007-11-06 NO NO20075671A patent/NO20075671L/no not_active Application Discontinuation
-
2010
- 2010-04-23 HK HK10104034.8A patent/HK1137219A1/xx not_active IP Right Cessation
- 2010-06-11 CY CY20101100535T patent/CY1110116T1/el unknown
-
2012
- 2012-02-21 US US13/401,397 patent/US20120196300A1/en not_active Abandoned
- 2012-04-18 NO NO20120452A patent/NO20120452L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1866650B1 (en) | 2010-05-19 |
HK1137219A1 (en) | 2010-07-23 |
JP2008537111A (ja) | 2008-09-11 |
NO20075671L (no) | 2007-11-06 |
SI1866650T1 (sl) | 2010-12-31 |
US20120196300A1 (en) | 2012-08-02 |
DK2146209T3 (da) | 2012-02-13 |
EP2146209A1 (en) | 2010-01-20 |
JP4958893B2 (ja) | 2012-06-20 |
PT2146209E (pt) | 2011-12-30 |
DE602006014379D1 (de) | 2010-07-01 |
WO2006105907A1 (en) | 2006-10-12 |
DK1866650T3 (da) | 2010-09-06 |
PL2146209T3 (pl) | 2012-05-31 |
EP2146209B1 (en) | 2011-11-16 |
EP1866650A1 (en) | 2007-12-19 |
ATE468537T1 (de) | 2010-06-15 |
ATE534038T1 (de) | 2011-12-15 |
ES2377704T3 (es) | 2012-03-30 |
ES2346467T3 (es) | 2010-10-15 |
PT1866650E (pt) | 2010-06-01 |
NO20120452L (no) | 2007-11-06 |
US20080131921A1 (en) | 2008-06-05 |
PL1866650T3 (pl) | 2011-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1110116T1 (el) | Νευροεκφυλιστικοι δεικτες για καταθλιψη | |
WO2006134390A3 (en) | Method for diagnosing neurodegenerative disease | |
MX2007016136A (es) | Metodo para diagnosticar la enfermedad de alzheimer. | |
WO2005045393A3 (en) | Determination of a measure of a glycation end-product or disease state using tissue fluorescence | |
WO2008089994A8 (en) | Use of igfbp-7 in the assessment of heart failure | |
WO2008148072A3 (en) | Disease-associated genetic variations and methods for obtaining and using same | |
IL163636A0 (en) | Device, system and method for temperature sensing in an in-vivo device | |
WO2006090389A3 (en) | Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof | |
WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
WO2007106762A3 (en) | Alzheimer's disease biomarkers and methods of use | |
PL2021794T3 (pl) | Zastosowanie białka S100A 12 jako markera raka okrężnicy i odbytnicy | |
ATE551357T1 (de) | Markerpeptid für die alzheimer-krankheit | |
DE602004006664D1 (de) | Vorrichtung zum Feststellen der Verschlechterung eines Sauerstoffkonzentrationsensors | |
FR2874675B1 (fr) | Frein pour roue avec capteur d'usure | |
DE602007006671D1 (de) | Verwendung von nnmt als marker für lungenkrebs | |
WO2006066917A3 (en) | Use of asc as a marker for colorectal cancer | |
WO2007060647A3 (en) | A method for detecting or monitoring sepsis by analysing cytokine mrna expression levels | |
WO2010000467A8 (en) | Asc as a marker for lung cancer | |
DE602007004570D1 (de) | Verwendung von Nogo-C bei der Beurteilung von Herzversagen | |
WO2010043393A8 (en) | Use of biglycan in the assessment of heart failure | |
ATE414904T1 (de) | Verfahren zum testen des oxidiertes-ldl-beta-2- glycoprotein-i-komplexes in vivo | |
ATE442084T1 (de) | Messung des energieverbrauchs | |
ATE530548T1 (de) | Neue dibenzoäc,hüä1,5ü naphthyridine und ihre verwendung als dna-sonden | |
BRPI0417802A (pt) | adaptador de capnÈmetro nanoelétrico | |
FR2852096B1 (fr) | Instrument indicateur de direction permettant d'indiquer l'heure et la direction de la mecque. |